This announcement is a separate document:
Appili Therapeutics Inc: ON FORM 13-502F1 (CLASS 1 AND 3B REPORTING ISSUERS - PARTICIPATION FEE)
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
08:31
This year's New Year's Eve market has already started.
SSE Composite Index-2.01%
08:30
Multiple factors are giving rise to a year-end market rally, and next year, the domestic policy environment will remain friendly to the Capital Markets.
08:27
HAITONG SEC assists the Bank of Shanghai in successfully issuing the first phase of specialized financial Bonds for small and micro enterprises in 2024.
Bank of Shanghai-2.66%